So what actually is plasma exchange?
Your blood has two main components. There are the blood cells — the red ones that carry oxygen, the white ones that fight infection. And then there's everything else, suspended in a yellowish liquid called plasma.
Plasma makes up roughly half your blood volume. It carries proteins, hormones, immune signaling molecules, nutrients, and — as two decades of research have increasingly shown — substances that accumulate over time that your body would be better off without.
Therapeutic Plasma Exchange (TPE) is a medical procedure where your blood flows out through a machine, the plasma gets separated from your blood cells, and then that plasma is replaced with a clean substitute fluid. Your blood cells come back to you. The plasma — and whatever was floating in it — does not. Patients who want a practical overview of how this is delivered clinically can reviewAvinity's PlasmaRestore™ therapeutic plasma exchange protocol.
Think of your plasma like the oil in a car engine. Over time, engine oil accumulates combustion byproducts and debris — it doesn't stop working entirely, but it becomes less effective and carries things that don't belong there. An oil change removes the old oil and replaces it with fresh fluid. The engine — your blood cells — stays exactly where it is throughout the whole process. And just like a car needs oil changes periodically rather than just once, plasma exchange works best as a series of treatments rather than a single session.
The procedure uses a medical device called an apheresis machine. It processes your blood continuously, separating it into components, returning your blood cells, and mixing in a replacement fluid called albumin — a protein solution that restores your blood's volume and structure. A typical session takes three to five hours. You're seated or reclined throughout, with an IV in one or both arms. Most people describe it as long but not uncomfortable.
How is this different from plasma donation or plasmapheresis?
These three terms get used interchangeably online — and they shouldn't be. The confusion is widespread enough that search results for "plasma exchange near me" frequently return plasma donation centers alongside actual TPE clinics. Here's the clear distinction.
| Factor | Plasma Donation | Plasmapheresis | Therapeutic Plasma Exchange |
|---|---|---|---|
| What it's for | Donor gives plasma for pharmaceutical or transfusion use | Broad term for any process separating plasma from blood cells | Physician-prescribed procedure to remove substances from your own blood |
| Who benefits | Plasma banks and pharmaceutical manufacturers | Varies — can be donation or treatment | You, the patient receiving treatment |
| Replacement fluid | None — your blood cells are returned, plasma is kept | Depends on the application | 5% albumin or fresh frozen plasma, returned to you |
| Medical oversight | Minimal — standardized screening only | Varies widely | Required — physician evaluation, monitoring, and follow-up |
| Volume treated | Fixed amount set by the donation center | Varies | Calculated for your body from weight and blood count |
| Compensation or cost | You're paid $50–$150 per visit | — | You pay; insurance coverage depends on your indication |
Why would removing plasma do anything useful?
This is the right question. The answer comes from about twenty years of research that has led to a conclusion that has surprised a lot of people in medicine.
This idea traces back to a strange series of experiments that began in 2005, when researchers surgically joined the circulatory systems of an old mouse and a young mouse — a technique called parabiosis. The old mouse's tissues started showing signs of repair. That was surprising enough on its own. But the more important finding came later: young mice joined to old partners got worse, not better. Whatever was in the old blood was actively holding tissue back — not just failing to help it.
A few years later, in 2011, researchers identified one of the specific culprits — a signaling molecule that rises with age and appears to suppress the brain's ability to generate new cells. Then in 2016, a study designed to separate the effects of blood exchange from the surgical joining itself found that a single exchange of old blood into young mice was enough to reduce regeneration in muscle, liver, and brain tissue. The inhibitory effect of old blood turned out to be stronger than any benefit from young blood.
The turning point for human treatment came in 2020, when researchers showed that young blood wasn't actually necessary. Replacing half of an old mouse's plasma with a plain saline-and-albumin solution — no young blood involved — reversed the same aging markers. That result is essentially what a plasma exchange session does in a person. It's also the moment this research stopped being a curiosity about mice and became something translatable to a clinical procedure.
What gets removed?
- Inflammatory signaling proteins that may be driving chronic low-grade inflammation
- Autoantibodies — immune molecules that can mistakenly attack your own tissues
- Age-associated secretory factors that research links to impaired tissue function
- Misfolded proteins associated with neurodegenerative conditions
- Lipoproteins including LDL and Lp(a), in specific cardiovascular applications
- Protein-bound heavy metals including mercury, in specialized protocols
Your body keeps making the proteins, immune factors, and signaling molecules that get removed. One session clears roughly 63%. But in the weeks that follow, those substances rebuild. A treatment series is designed to stay ahead of that rebuilding long enough to produce a sustained biological shift — which is why every published study showing meaningful results used multiple sessions, not just one.
What does the research actually show?
The studies below span two decades — from mouse experiments to a 2026 human trial. Here they are in plain language, in the order they happened, with what each one actually found.
Researchers surgically connected the circulatory systems of old and young mice and found that old tissue showed signs of repair — but young tissue joined to an old partner got measurably worse. Follow-up work through 2016 confirmed that a single exchange of old blood was enough to suppress regeneration in young animals, even without any surgical joining at all.
Old blood doesn't just lack youthful ingredients — it appears to actively hold tissue back. That's the finding this whole field is built on.
This study showed that young blood wasn't actually required to see the effect. Replacing half of an old mouse's plasma with a neutral saline-and-albumin solution — the animal equivalent of a plasma exchange session — reversed markers of tissue aging in muscle, liver, and brain. The researchers also analyzed real human plasma samples taken from TPE patients and found the same pattern: inflammatory proteins went down, repair-associated proteins went up.
You don't need someone else's blood. Simply diluting and replacing what's already there seems to be enough — and the human samples backed that up.
The first study to measure whether TPE changes a person's biological age, not just their chronological age. Older adults who received five or more sessions showed reductions of about one to two years in biological age, measured through epigenetic clocks and blood protein markers, along with improved immune profiles and reduced markers of cellular aging.
This is where the research moved from mice to a measurable effect in real people — a small but real shift in the markers scientists use to estimate how "old" your body is acting.
A randomized trial comparing different treatment schedules across 30 participants, using one of the most comprehensive biological-age testing panels ever applied to a TPE study. The group receiving TPE combined with an immune-support infusion (IVIG) every two weeks showed the strongest result — about a 2.61-year reduction in measured biological age after just three sessions. TPE alone showed effects too, but they were smaller and less consistent.
The biggest effect came from a specific combination — TPE plus IVIG — not from TPE by itself. That distinction matters if you're comparing what a clinic is actually offering you.
The first peer-reviewed human study to test whether plasma exchange can reduce circulating microplastics. Across 114 patients and 174 sessions, people who started with higher microplastic levels saw a large, statistically significant drop. People who started with lower levels didn't see much benefit — partly because the plastic tubing used in the procedure itself sheds a small amount of microplastic back into the blood.
Real effect, real limitation. It works best for people who have more to remove, and even then, it only measures what's circulating in blood — not everything stored in your body's tissues.
Want the full clinical detail?
Our clinical reference includes every study citation with DOI and PubMed links, ASFA evidence classifications, protocol comparison tables, mechanism detail, and schema-structured data for researchers and clinicians.
What is plasma exchange actually used for?
TPE spans a wide range of uses — from decades-old, well-established medical treatments to early-stage research that hasn't been proven yet. Here's an honest picture of where each application actually stands.
What actually happens during a session?
Here's what a typical outpatient treatment day actually looks like, from the evaluation that happens before you're ever scheduled to the follow-up that happens after.
For a closer look at how Avinity structures a treatment day from arrival to discharge, see our full overview of thePlasmaRestore™ protocol.
What does it cost?
Cost varies a lot depending on where you're treated and why. Here's an honest breakdown of the ranges and what actually drives the price.
Is this right for you?
TPE isn't right for everyone, and a responsible provider will tell you that. The criteria below reflect what's typically evaluated before treatment is recommended — seewho is generally a good candidate for PlasmaRestore™for more detail on Avinity's evaluation process.
- Generally good overall health with stable vital signs
- Chronic conditions present but clinically stable
- Hemoglobin at or above standard thresholds (12 g/dL men, 11 g/dL women)
- Platelet count at or above 100,000/µL
- Fibrinogen at or above 100 mg/dL
- Normal kidney and liver function on recent labs
- Able to sit still with arms in place for 3–5 hours
- Willing to provide written informed consent
- Known allergy to albumin or blood products
- Currently taking an ACE inhibitor (must be stopped 48 hours prior)
- Unstable chronic medical conditions
- Lab values outside safe thresholds
- Inability to maintain IV access for the full session
- Unable or unwilling to provide informed consent
What should I ask a provider about treatment?
The quality of a TPE program often isn't visible on a clinic's website. These are the questions that actually reveal how rigorous a provider is.
About the physician
- Is the supervising physician board-certified in nephrology, hematology, or apheresis medicine specifically?
- Does the physician personally perform or directly supervise plasma exchange procedures — not just prescribe them?
- How many years of hands-on apheresis experience does the physician have?
About your treatment plan
- Is my exchange volume calculated from my own body weight and blood count, or is it the same fixed amount for every patient?
- What percentage of my total plasma volume will actually be exchanged?
- What replacement fluid will be used, and why is that the right choice for me?
- How will my plan be adjusted if my results differ from what's expected?
About the nursing team
- How many nurses are assigned to my session?
- Are they trained specifically in apheresis nursing, not just general infusion care?
- Is there continuous coverage in the room for the entire session? Two is the standard.
- What is the plan if something goes wrong during my treatment?
About their claims
- If a treatment is described as helping with aging, mold illness, or microplastics, can you show me the published, peer-reviewed research it's based on?
- Is this application considered established, or investigational and still being studied?
- How is candidacy determined — by a physician evaluation, or by a sales conversation?
A provider who's confident in their program will answer these questions specifically and without hesitation — citing your actual lab values, naming their board certification, and being upfront about what's proven versus what's still being studied. Vague reassurance in place of specifics is itself an answer.
Ready to find out if you're a candidate?
Our medical team — including specialists in nephrology and therapeutic apheresis — reviews each patient individually through a structured candidacy evaluation before any treatment recommendation is made.
Questions people actually ask
Is this the same as donating plasma?
No. When you donate plasma, you're a healthy volunteer giving away your plasma for someone else's use, and you get paid for it. With TPE, your own plasma is removed and replaced by a physician, for your own treatment — and you're the one paying, not getting paid. Different purpose, different setting, different oversight entirely.
Does it hurt?
Not really. You'll feel a needle stick for IV placement, similar to a blood draw, and then sit or recline for the 3–5 hour session. Most patients describe it as long and a little tedious, not painful.
How much plasma actually gets removed?
A standard single-volume exchange removes about 63% of what's circulating in your plasma. Going up to 1.5 times your plasma volume increases that to roughly 75–80%. The exact amount should be calculated for your body specifically, not applied as a fixed number for everyone.
Why do you need multiple sessions?
Your body keeps producing the same proteins and antibodies that get removed, so a single session's effects fade as your body rebuilds them. A series of sessions is designed to stay ahead of that rebuilding long enough to produce a lasting shift — every study that's shown meaningful results used multiple sessions, not one.
Is there real research supporting this for longevity?
Yes, published and peer-reviewed — but it's still early. A 2022 study found roughly 1–2 years of reduction in measured biological age after five or more sessions. A 2025 trial found up to 2.61 years of reduction, but specifically in patients who received TPE combined with IVIG, not TPE alone. These are real, measured changes in biological markers — they aren't yet proof of longer lifespan or fewer diseases.
What about microplastics and mold?
Microplastics: a 2026 study found TPE can reduce circulating microplastic levels, but only in patients who started with higher levels, and the tubing used in the procedure itself sheds a small amount back in. Mold and mycotoxins: there's no published research supporting TPE for this at all. Be skeptical of any provider claiming otherwise without showing you the study.
Why does it matter whether the doctor is a nephrologist?
Because this procedure replaces 1 to 1.5 times your entire plasma volume, and things can go sideways — fluid shifts, electrolyte changes, clotting factor drops. A physician with real nephrology or apheresis training has hands-on experience managing those exact situations. A provider whose background is mainly aesthetics or general wellness may not.
How many nurses should be in the room?
Two. This procedure needs continuous, uninterrupted monitoring — one nurse manages the apheresis machine and circuit, the other stays with you. If a clinic runs sessions with a single nurse, there will be moments with no one watching you, which isn't an acceptable standard for a procedure replacing this much of your blood volume.
How is this different from an IV drip or infusion?
An IV drip adds something to your blood. TPE removes something from your blood — plasma and whatever is dissolved in it — and replaces the volume with a substitute fluid. It's a fundamentally different, more involved procedure requiring specialized equipment and closer monitoring than a standard infusion.
Medical Disclaimer: This page is written in plain language for patient education only and does not constitute medical advice, diagnosis, or treatment recommendation. Research references reflect published literature and should not be interpreted as established clinical efficacy for elective or investigational applications. Therapeutic plasma exchange requires individual physician evaluation and candidacy assessment. Avinity Health, 11000 N. Scottsdale Road, Suite 100, Scottsdale, Arizona 85254.